Add-On Homeopathy Linked to Better Quality of Life and Longer Survival in Advanced Lung Cancer Trial
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, ...
Deep inside every chronically failing kidney, a quiet molecular drama unfolds. Scar tissue slowly strangles the delicate ...
Iambic’s $150 million IPO nets an estimated $135 million and may fund operations through 2028; its lead AI-discovered cancer ...
Madrigal announced an update on their ongoing clinical study. The study “Resmetirom in Patients With MASH and HFpEF” tests Madrigal’s liver drug in people who also have a co ...
AbbVie (NYSE: ABBV) today announced the presentation of 20 new scientific abstracts from its IBD portfolio at the 2026 United European Gastroenterology (UEG) Week, October 17-20 in Barcelona, Spain.
On September 16, 2026, the indication for the breast cancer drug Ibrance (generic name: palbociclib) was expanded in ...
## 摘要 ### 背景 乳腺癌是法国乃至全球女性中最常见的癌症，约四分之一的病例发生在50岁之前。这些年轻女性往往表现出更具侵袭性的肿瘤，需要更为积极的治疗方案。然而，化疗常会引起 ...
스위스 빅파마 노바티스가 경구용 보체 B인자 억제제 '파발타(Fabhalta, 성분명 입타코판)'의 루푸스 신염 적응증 확대를 위한 임상 2상 시험을 중단했다. 16일(현지시간) 로이터통신과 미국 임상시험 등록사이트 ...
صرحت إدارة الغذاء والدواء الأميركية بالموافقة على دواء جديد لعلاج آفات الهربس وهي على شكل أقراص تؤخذ عن طريق الفم مرة واحدة ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results